Skip to main content

Table 3 Association of blood lipid profile and IL-6 with hip BMD stratified by sex

From: The diagnostic value of the combined application of blood lipid metabolism markers and interleukin-6 in osteoporosis and osteopenia

 

Male

Female

β (95% CI)

P value

β (95% CI)

P value

Model 1

 TG (mmol/l)

0.021 (-0.006–0.048)

0.124

0.006 (-0.022, 0.034)

0.682

 TC (mmol/l)

-0.020 (-0.044–0.005)

0.114

-0.006 (-0.022, 0.034)

0.682

 ApoA1(g/l)

-0.009 (-0.144–0.125)

0.889

-0.066 (-0.146, 0.015)

0.109

 ApoB (g/l)

-0.074 (-0.177–0.030)

0.161

0.005 (-0.083, 0.093)

0.909

 ApoA1/ApoB

0.021 (-0.042–0.084)

0.516

-0.034 (-0.074–0.006)

0.095

 HDL-C (mmol/l)

-0.050 (-0.180–0.080)

0.445

-0.053 (-0.137, 0.031)

0.215

 LDL-C (mmol/l)

-0.030 (-0.066–0.006)

0.099

0.005 (-0.025, 0.035)

0.732

 FFA (mmol/l)

-0.195 (-0.334–-0.055)

0.007*

-0.244 (-0.348, -0.140)

<0.001*

 IL-6 (pg/ml)

-0.005 (-0.007–-0.002)

0.002*

-0.007 (-0.009, -0.005)

<0.001*

Model 2

 TG (mmol/l)

0.017 (-0.009–0.044)

0.202

0.010 (-0.011, 0.032)

0.343

 TC (mmol/l)

-0.027 (-0.051–-0.003)

0.031*

-0.016 (-0.031, -0.001)

0.043*

 ApoA1(g/l)

-0.003 (-0.134–0.128)

0.961

-0.062 (-0.123, -0.001)

0.047*

 ApoB (g/l)

-0.100 (-0.201–0.001)

0.053

-0.047 (-0.115, 0.020)

0.169

 ApoA1/ApoB

0.040 (-0.023–0.102)

0.208

-0.008 (-0.039–0.023)

0.632

 HDL-C (mmol/l)

-0.037 (-0.164–0.089)

0.558

-0.062 (-0.125, -0.002)

0.056

 LDL-C (mmol/L)

-0.043 (-0.079–-0.008)

0.017*

-0.013 (-0.036, 0.009)

0.248

 FFA (mmol/l)

-0.171 (-0.309–-0.033)

0.016*

-0.102 (-0.189, -0.015)

0.022*

 IL-6 (pg/ml)

-0.004 (-0.007–-0.001)

0.011*

-0.002 (-0.005, 0.001)

0.033*

  1. *P < 0.05